Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Azepines | 1 | 2010 | 2 | 0.330 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 2 | 2009 | 7 | 0.320 |
Why?
|
| Pyrimidines | 1 | 2010 | 77 | 0.310 |
Why?
|
| Pyrimidinones | 1 | 2009 | 7 | 0.300 |
Why?
|
| Kainic Acid | 2 | 2005 | 11 | 0.280 |
Why?
|
| Trichophyton | 1 | 2008 | 1 | 0.280 |
Why?
|
| Tinea | 1 | 2008 | 5 | 0.280 |
Why?
|
| Antifungal Agents | 1 | 2008 | 44 | 0.270 |
Why?
|
| Aza Compounds | 1 | 2005 | 4 | 0.230 |
Why?
|
| Amino Acids | 1 | 2005 | 52 | 0.220 |
Why?
|
| Alkenes | 1 | 2005 | 4 | 0.220 |
Why?
|
| Cryosurgery | 1 | 2004 | 25 | 0.210 |
Why?
|
| Molecular Structure | 3 | 2010 | 58 | 0.190 |
Why?
|
| Skin Diseases | 1 | 2004 | 135 | 0.180 |
Why?
|
| Dogs | 3 | 2010 | 125 | 0.170 |
Why?
|
| Urinary Incontinence | 2 | 2010 | 68 | 0.150 |
Why?
|
| Pyrrolidines | 2 | 2009 | 15 | 0.130 |
Why?
|
| Structure-Activity Relationship | 3 | 2009 | 88 | 0.110 |
Why?
|
| TRPM Cation Channels | 1 | 2014 | 8 | 0.110 |
Why?
|
| Stockings, Compression | 1 | 2013 | 2 | 0.100 |
Why?
|
| Varicose Ulcer | 1 | 2013 | 4 | 0.100 |
Why?
|
| Animals | 5 | 2014 | 8165 | 0.100 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 2 | 2009 | 4 | 0.090 |
Why?
|
| Rats | 3 | 2014 | 1892 | 0.090 |
Why?
|
| Pain | 1 | 2014 | 303 | 0.090 |
Why?
|
| Family Practice | 1 | 2011 | 49 | 0.080 |
Why?
|
| Social Support | 1 | 2011 | 181 | 0.080 |
Why?
|
| Stereoisomerism | 2 | 2009 | 26 | 0.080 |
Why?
|
| Cricetulus | 1 | 2009 | 21 | 0.080 |
Why?
|
| CHO Cells | 1 | 2009 | 27 | 0.080 |
Why?
|
| Pyridazines | 1 | 2009 | 8 | 0.080 |
Why?
|
| Cricetinae | 1 | 2009 | 49 | 0.070 |
Why?
|
| Physicians | 1 | 2011 | 163 | 0.070 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2009 | 5 | 0.070 |
Why?
|
| Piperazines | 1 | 2009 | 60 | 0.070 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2009 | 41 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2009 | 101 | 0.070 |
Why?
|
| Tinea Capitis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Tinea Pedis | 1 | 2008 | 4 | 0.070 |
Why?
|
| Child Welfare | 1 | 2008 | 18 | 0.070 |
Why?
|
| Urethra | 1 | 2009 | 125 | 0.070 |
Why?
|
| Piperidines | 1 | 2009 | 137 | 0.070 |
Why?
|
| Administration, Topical | 1 | 2008 | 141 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2008 | 201 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2011 | 317 | 0.070 |
Why?
|
| Humans | 7 | 2014 | 32284 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 1073 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 709 | 0.060 |
Why?
|
| Alcohols | 1 | 2005 | 3 | 0.060 |
Why?
|
| Cyclization | 1 | 2005 | 3 | 0.060 |
Why?
|
| Alkylation | 1 | 2005 | 7 | 0.060 |
Why?
|
| Hydrogen | 1 | 2005 | 9 | 0.060 |
Why?
|
| Sulfur | 1 | 2005 | 5 | 0.060 |
Why?
|
| Iodine | 1 | 2005 | 7 | 0.060 |
Why?
|
| Lactones | 1 | 2005 | 13 | 0.060 |
Why?
|
| Free Radicals | 1 | 2005 | 10 | 0.060 |
Why?
|
| Temperature | 1 | 2005 | 58 | 0.060 |
Why?
|
| Sulfhydryl Compounds | 1 | 2005 | 30 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2005 | 14 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 71 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 255 | 0.050 |
Why?
|
| Pharmaceutical Solutions | 1 | 2004 | 2 | 0.050 |
Why?
|
| Nitrogen | 1 | 2004 | 10 | 0.050 |
Why?
|
| Forms and Records Control | 1 | 2004 | 8 | 0.050 |
Why?
|
| United States | 2 | 2011 | 4079 | 0.050 |
Why?
|
| Child | 1 | 2008 | 2446 | 0.040 |
Why?
|
| Risk Factors | 1 | 2008 | 3938 | 0.040 |
Why?
|
| Male | 3 | 2014 | 19434 | 0.040 |
Why?
|
| Drug Design | 2 | 2009 | 51 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2014 | 16 | 0.030 |
Why?
|
| Body Temperature | 1 | 2014 | 19 | 0.030 |
Why?
|
| Membrane Transport Modulators | 1 | 2014 | 7 | 0.030 |
Why?
|
| Oxycodone | 1 | 2014 | 7 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2014 | 111 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 96 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2014 | 57 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 566 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 212 | 0.020 |
Why?
|
| Physician Executives | 1 | 2011 | 12 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 171 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 130 | 0.020 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2009 | 8 | 0.020 |
Why?
|
| Serotonin | 1 | 2009 | 44 | 0.020 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2009 | 75 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 1485 | 0.020 |
Why?
|
| Adult | 1 | 2011 | 9263 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 10257 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 11843 | 0.010 |
Why?
|
| Female | 1 | 2011 | 19954 | 0.010 |
Why?
|